This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The FDA Center for Veterinary Medicine (CVM)’s draft guidance on pharmaceutical development for veterinary medicines outlines a systematic approach to ensure the quality, safety, and efficacy of veterinary drugs.
Understand the Scope: First and foremost, understand the electronic systems you use and determine which records are subject to 21 CFR Part 11. Implement Secure Systems: Invest in software and hardware systems that provide secure access control, audit trail capabilities, and electronic signature features.
In today’s digital age, the enormous amount of data generated in clinical studies necessitates the need for powerful, dynamic digital tools that provide data integration in real time from which insights can be garnered to help inform clinical decisions. It has kind of been a black box until you develop tools that allow for that.”
Cannabis-infused products primarily contain the cannabinoids cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC). THC is main psychoactive cannabinoid, which is used in recreational products. The market for cannabis-infused products is growing like weed. Which Countries have Legalized the Use of Medical Cannabis?
Complex User Interfaces: Many legacy systems had cumbersome and outdated user interfaces that were not user-friendly. This complexity made it difficult for trial managers and site staff to navigate the system efficiently, leading to potential errors and reduced productivity.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content